Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

New flu vaccine studied for kidney transplant patients

NCT ID NCT01086904

First seen Feb 24, 2026 · Last updated Jun 15, 2026 · Updated 15 times

Summary

This study tested a flu vaccine (H1N1) in 122 kidney transplant patients to see if it is safe and helps their immune system fight the flu. Participants were adults who had a kidney transplant at least 6 months ago and were on stable immunosuppressive drugs. The vaccine was given without an adjuvant to avoid overstimulating the immune system.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNOSUPPRESSION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Centre hospitalier Lyon Sud, service de néphrologie transplantation

    Pierre-Bénite, Lyon, 69495, France

  • Hôpital E. Herriot , Service de néphrologie, transplantation et immunologie clinique

    Lyon, 69437, France

  • Service d'urologie, GH Pitié Salpêtrière

    Paris, 75013, France

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.